Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression
- DOI
- 10.1038/s41408-025-01382-x
- Published
- 2025-10-27
- Container
- Blood Cancer Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-025-01382-x,
title = {Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression},
author = {Shady I. Tantawy and Burcu Aslan and Ganiraju Manyam and LaKesla R. Iles and Natalia Timofeeva and Neetu Singh and Nitin Jain and Alessandra Ferrajoli and Philip A. Thompson and Keyur P. Patel and Sai Prasad Desikan and William G. Wierda and Varsha Gandhi},
year = {2025},
journal = {Blood Cancer Journal},
doi = {10.1038/s41408-025-01382-x},
url = {https://doi.org/10.1038/s41408-025-01382-x}
}RIS
TY - JOUR TI - Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression AU - Shady I. Tantawy AU - Burcu Aslan AU - Ganiraju Manyam AU - LaKesla R. Iles AU - Natalia Timofeeva AU - Neetu Singh AU - Nitin Jain AU - Alessandra Ferrajoli AU - Philip A. Thompson AU - Keyur P. Patel AU - Sai Prasad Desikan AU - William G. Wierda AU - Varsha Gandhi PY - 2025 JO - Blood Cancer Journal DO - 10.1038/s41408-025-01382-x UR - https://doi.org/10.1038/s41408-025-01382-x ER -
APA
Tantawy, S. I., Aslan, B., Manyam, G., Iles, L. R., Timofeeva, N., Singh, N., Jain, N., Ferrajoli, A., Thompson, P. A., Patel, K. P., Desikan, S. P., Wierda, W. G., & Gandhi, V. (2025). Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression. Blood Cancer Journal. https://doi.org/10.1038/s41408-025-01382-x
Source records
- crossref · retrieved 2026-09-28T16:27:30.576Z